Cytokine networks in the pathogenesis of rheumatoid arthritis

N Kondo, T Kuroda, D Kobayashi - International journal of molecular …, 2021 - mdpi.com
pathophysiology of RA, and that some of them might become targets for future therapeutics.
Here we review … , IL-33, granulocyte macrophage colony-stimulating factor (GM-CSF), and IL-…

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

…, SA Bergstra, A Kerschbaumer, A Sepriano… - … of the rheumatic …, 2023 - ard.bmj.com
… of pharmacological treatment in rheumatoid arthritis: a systematic literature research Informing
the 2019 update of the EULAR recommendations for management of rheumatoid arthritis. …

Management of rheumatoid arthritis: an overview

AF Radu, SG Bungau - Cells, 2021 - mdpi.com
… research perspectives in the treatment of RA that could lead … rheumatoid arthritis“). A total
of 240 bibliographic references were selected and cited to validate the information in this review

Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis

YJ Lin, M Anzaghe, S Schülke - Cells, 2020 - mdpi.com
… symptoms and prevent disease progression in RA patients, they are associated with … review
summarizes our current understanding of the underlying pathomechanism, diagnosis of RA

American College of Rheumatology/EULAR remission criteria for rheumatoid arthritis: 2022 revision

P Studenic, D Aletaha, M de Wit, TA Stamm… - … of the Rheumatic …, 2023 - ard.bmj.com
… score (mTSS) between baseline and 1 year) and the proportions of … 1 year (HAQ≤0.5)
were assessed. Attaining an HAQ of≤0.5 without radiographic progression at 1 year of treatment

Fibromyalgia: one year in review 2023

V Giorgi, L Bazzichi, A Batticciotto… - … Rheumatology, 2023 - air.unimi.it
… the association between childhood mala treatment and FM: the … the development of FM
rather than rheumatoid arthritis (8). A … One review (40) of the pathogenic processes of both …

Osteoporosis in patients with rheumatoid arthritis: an update in epidemiology, pathogenesis, and fracture prevention

HG Raterman, IE Bultink, WF Lems - Expert opinion on …, 2020 - Taylor & Francis
… In this study with 12 months follow up it was observed that TPTD treatment for 1 year does
not significantly reduce erosion volume in the hands or wrists of patients with established RA

Rheumatoid arthritis–associated interstitial lung disease: an overview of epidemiology, pathogenesis and management

Y Dai, W Wang, Y Yu, S Hu - Clinical rheumatology, 2021 - Springer
… In this review, we focus on discussing the epidemiology and pathogenesis of RA-ILD,
establishing the diagnosis of ILD in RA, evaluating disease activity and prognosis and the …

Signaling pathways in rheumatoid arthritis: implications for targeted therapy

Q Ding, W Hu, R Wang, Q Yang, M Zhu, M Li… - Signal transduction and …, 2023 - nature.com
… as inhibitors of RA-linked signaling systems. This review will generally introduce the risk
factor and pathogenesis of RA, mainly describing the signal transduction pathways that impact …

The association between systemic immune-inflammation index and rheumatoid arthritis: evidence from NHANES 1999–2018

B Liu, J Wang, Y Li, K Li, Q Zhang - Arthritis research & therapy, 2023 - Springer
… Previous studies have shown that the pathogenesis of rheumatoid arthritis is complex. At …
can also lead to rheumatoid arthritis, such as interleukin (IL)-17, tumor necrosis factor (TNF-α), …